Approvals/TGA/ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe

Approved

STANDARD

ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e85095b8480041eb
Product Name: ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe
Artg Id: 326047
Artg Name: ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2020-11-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0565b3480e119d7dbbb5b5cbee3f57eb.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/894583f17c2d41e6386708381e8cd723.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e85095b8480041eb

Type

Standard